New Delhi, Aug 12 - It is ironical that Pune reported the first loss of life due to swine flu in India as it is home to the country's largest biotech firm, which is also among the world's leading players trying to develop a vaccine to fight the H1N1 virus.

At the Serum Institute of India, a crack team of 16 scientists is running a battle against time as part of the global race to develop vaccines against the spread of swine flu that has claimed 10 lives in India, of which five were in Pune alone.

This team started work a few weeks after the first influenza A infection caused by a new virulent strain H1N1 was first detected April 12 in a small village near Veracruz in Mexico, says Technology Review magazine.

The scientists are working out of a state-of-the-art facility that meets global standards, called BioSafety Level2, says the Indian edition of the 109-year-old magazine brought out by the CyberMedia group.

'The flu transmission didn't stop even after the increase in the summer temperatures,' said Suresh S. Jadhav, executive director with the Serum Institute and coordinator of the company's swine flu vaccine initiative.

'Studies have indicated that people born after 1975 were more vulnerable due to the inability of their immune system to recognise this H1N1 virus strain,' Jadhav was quoted as saying in the magazine.

Technology Review says the World Health Organisation (WHO) has roped in as many companies as possible with expertise in manufacturing vaccines to develop inoculations against the H1N1 influenza strain.